Chasing invasive cancer cells with a laser

December 07, 2015

What makes invasive cancer cells behave differently than the other cells in the tumor from which they arise? Let's turn them red with a laser and find out.

That's the experimental approach taken by scientists from Winship Cancer Institute of Emory University who will present their work on Sunday, December 13, 2015 at the American Society for Cell Biology meeting at San Diego Convention Center.

The idea of precision medicine is based on the observation that cancer cells in two different people may respond differently to treatment, based on the mutations that drive the cells' growth, even though they may come from the same organ and even look similar under the microscope.

Cell biologist Adam Marcus and graduate student Jessica Konen are extending that concept to highlight how even in a single tumor, not all the cells are the same. Some may divide or migrate faster than others. A few cells might survive chemotherapy that kills the rest.

In the accompanying video (see below), Marcus and Konen explain how they came up with the combination of labeling a few lung cancer cells in culture, by changing them from fluorescent green to fluorescent red, and sorting out the labeled cells. The technique, which the researchers call spatiotemporal genomic analysis or SAGA, seeks to probe differences in cellular behavior.

This technique allows scientists to ask and answer questions such as: Is the property of migrating faster (being a "leader cell") long-lasting and stable? Is that property connected with changes in the cell's DNA? Do leader cells and follower cells need each other to cause metastatic disease?

This approach is expected to yield new insights into cancer cell biology, which may lead to new treatments that hamper metastasis.

This November, a video featuring Marcus and Konen won first prize in the 2015 GRAND Basic Research video contest sponsored by the Association of American Medical Colleges.

Konen's presentation is scheduled for Minisymposium 1: Cell Migration in Tissues, 4 pm to 6:25 pm PST, Ballroom 20D.
-end-
Presentation schedule:

http://www.ascb.org/2015meeting/minisymposium-1-cell-migration-in-tissues/

Presentation abstract:

http://ascb.org/files/2015ASCBOralAbstracts.pdf [To find Konen and Marcus' abstract, search for SAGA]

Video:

http://medresearch.tumblr.com/GRANDwinner

Emory Health Sciences

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.